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Abstract
Background: Respiratory diseases cause substantial morbidity and mortality worldwide, with sub-Saharan Africa
bearing the greatest burden. Identifying etiologies of respiratory disease is important to inform cost effective
treatment, prevention and control strategies. Testing for all of the different pathogens that are potentially
associated with respiratory illnesses is challenging. We piloted the use of a multi-pathogen respiratory Taqman
Array Cards (TAC) to identify pathogens in respiratory samples collected from non-fatal and fatal cases and their
matched asymptomatic controls.
Methods: This is a case control study comparing viral and bacterial pathogens detected among non-fatal and fatal
cases to those detected among age and time matched asymptomatic controls. We used McNemar’s test to
compare proportions of pathogens detected among cases (non-fatal and fatal) to their matched asymptomatic
controls. We used Mann-Whitney test to compare the distribution of median Cycle threshold (Ct) values among
non-fatal and fatal cases to their corresponding asymptomatic controls.
Results: There were 72 fatal and 72 non-fatal cases matched to 72 controls. We identified at least one pathogen in
109/144 (76%) cases and 59/72 (82%) controls. For most pathogens, the median Ct values were lower among cases
(fatal and non-fatal) compared to asymptomatic controls.
Conclusions: Similar rates of pathogen detection among cases and controls make interpretation of results
challenging. Ct-values might be helpful in interpreting clinical relevance of detected pathogens using multi-
pathogen diagnostic tools.
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Background
Respiratory illnesses associated with bacteria, fungi or
viral infections cause substantial morbidity worldwide.
Specific etiology cannot be distinguished on basis of
clinical presentation alone. Understanding the relative
contribution of different pathogens to severe respiratory
illnesses could be an important tool to inform and
prioritize specific clinical interventions or public health
policies. Nonetheless, testing for all of the different
pathogens that are potentially associated with respiratory
illnesses is challenging.
Molecular-based multi-pathogen diagnostic tests such
as Taqman Array cards (TAC) may offer some resolution
to the diagnostic challenges of respiratory illnesses, espe-
cially in the setting of outbreaks of unknown etiology.
These tests are capable of detecting a broad range of
pathogens by multiplexing polymerase chain reaction
(PCR), and have a short turn-around-time of approxi-
mately 3 h [1]. We piloted the use of respiratory TAC to
identify pathogens in nasopharyngeal (NP) and oropha-
ryngeal (OP) specimens collected from hospitalized
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patients with respiratory illness (fatal and non-fatal
cases) and corresponding matched asymptomatic con-
trols. The hypothesis was that as we moved through the
spectrum of disease severity (from asymptomatic to fatal
cases), we would see changes in the types and frequency
of pathogens detected that could assist with interpret-
ation of disease etiology.
Methods
Participants and definitions
Clinical data on patients’ specimens collected from 1st
Aug 2009 through 31st Jul 2011 at Siaya County Referral
Hospital (Siaya CRH) and Lwak Mission Hospital (Lwak
MH) were obtained. Both hospitals are located in rural
western Kenya, and surveillance activities are operated
by the Kenya Medical Research Institute (KEMRI) in
collaboration with the U.S. Centers for Disease Control
and Prevention in Kenya (CDC-Kenya) [2, 3]. At Siaya
CRH, for consenting patients hospitalized with acute re-
spiratory illness (cases) demographic data were collected
using structured questionnaires if at least one of the fol-
lowing symptoms had been present during the previous
14 days: cough, difficulty breathing, sore throat, or chest
pain. In addition, NP/OP specimens were collected for
TAC testing. Cases were further classified as non-fatal if
they were discharged from hospital alive or fatal if they
died during hospitalization. We also enrolled asymptom-
atic controls among those visiting the outpatient clinic
at Lwak MH due to non-infectious conditions. Reasons
for outpatient visit could include drug refills, vaccination
services or well-visits; persons accompanying sick rela-
tives were also approached for enrollment as control.
Controls were excluded if they reported respiratory
symptoms, fever or diarrhea within 14 days prior to their
clinic visit [4]. Lwak MH is located at approximately
30 km from Siaya CRH, serving a similar population [5].
Initially, we identified non-fatal cases and matched them
individually with fatal cases based on age and date of ad-
mission (within +/− 30 days) at a ratio of one-to-one.
Then we identified a similar number of asymptomatic
controls within the same time-frame as the cases and
matched them in similar fashion (based on age and date
of admission) to the previously matched non-fatal and
fatal cases. The age-matching was done considering up
to 4 months difference for those aged <18 years, and a
5 year-band difference for those ≥18 years.
Laboratory methods
NP/OP swabs were combined in a single cryovial con-
taining 1 ml viral transport media (VTM). These speci-
mens were transported on the same day in cool boxes at
2-8 °C to the KEMRI laboratory (Kisumu, Kenya) where
they were stored at −80 °C until processed. Fifty microli-
ters of NP/OP specimen was tested using respiratory
TAC for viral targets [influenza virus type A, influenza
virus type B, respiratory syncytial virus (RSV), parainflu-
enza virus type I (PIV-1), PIV-2, PIV-3, Human metap-
neumovirus (HMPV), Rhinovirus /Enterovirus (RV/EV),
and Adenovirus (AV)] and bacterial targets [Streptococ-
cus pneumoniae, Haemophilus influenzae pan, Myco-
plasma pneumoniae and Bordetella pertussis] [6] [for
more details, see Additional file 1: Fig. S1 (Schematic
diagram of the two versions of Taqman array cards
(TAC) used in the study) in supplementary material]. A
positive result in TAC for each pathogen was defined as
cycle threshold (Ct) values <40.
Statistical analysis
We stratified the study population by age group and cal-
culated the prevalence of each virus detected from NP/
OP specimens collected from non-fatal and fatal cases
and asymptomatic controls. We used McNemar’s test to
compare the proportions of pathogens detected among
cases (non-fatal and fatal) to their matched asymptom-
atic controls. We used odds ratios (OR) to determine
pathogens associated with cases (non-fatal and fatal)
compared to controls. We used the median Ct value as a
proxy of pathogen density in the NP/OP specimen [7],
using the Mann-Whitney test to compare the distribu-
tion of the median Ct values between non-fatal and fatal
cases and their corresponding asymptomatic controls
separately for each pathogen identified. All statistical
analysis was carried out using Stata version 13.0 (Stata-
Corp. 2013. Stata Statistical Software: Release 13. College
Station, TX: StataCorp LP) and p-values <0.05 were
considered to statistically significant.
Results
There were equal number of fatal and non-fatal cases
and matched controls (n = 72 each). Of the total study-
patients (n = 216), 102 (47%) were aged <5 years and
114 (53%) were ≥5 years. For each age category, the me-
dian age was 1.5 years (range 3 - 59 months) for those
<5 years and 36 years (range 5 - 90 years) for those
≥5 years. Among non-fatal cases, 61 (85%) presented
with cough, 40 (56%) with difficulty in breathing, 17
(24%) with chest pain and 10 (29%) with sore throat
(these symptoms were not mutually exclusive). Among
fatal cases, 63 (88%) presented with cough, 45 (63%)
with difficulty in breathing, 19 (26%) with chest pain,
and 13 (41%) with sore throat.
Using TAC, we detected at least one pathogen from
109/144 (77%) cases. There was no difference in patho-
gen distribution among non-fatal and fatal cases based
on the presenting symptoms. Overall, among all cases,
there was a higher percent of viral co-detection (11%
had 2 viruses and 6% had ≥3 viruses detected) compared
to bacteria co-detection (7% had 2 bacteria detected and
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1% had ≥3 bacteria detected). There were more viral co-
detections among non-fatal cases, with 6(8%) having ≥3
viruses detected compared to 3(4%) among fatal cases;
but total number of detected pathogens were similar in
the two groups (n = 54 vs n = 55 among non-fatal and
fatal cases respectively). Children <5 years had a higher
percent of pathogens detected than those ≥5 years: 100%
vs 52% among non-fatal, and 88% vs 66% among fatal
cases, respectively (Additional file 1: Table S1). We
detected at least one pathogen from 59/72 (82%) asymp-
tomatic controls with higher co-detection of bacteria
(44% had 2 bacteria) compared to viruses (15% had 2 vi-
ruses). Only 4/72 (6%) asymptomatic controls developed
an illness after sample collection. One developed respira-
tory symptoms 6 days after being swabbed (originally
had rhinovirus detected in the study sample); one
developed fever 3 days after being swabbed (had no
pathogens detected); one developed unspecified non-re-
spiratory symptoms 3 days after sample collection (had
enterovirus, Haemophilus influenzae and S. pneumoniae
detected in the study sample); and one developed respira-
tory symptoms 1 day after the NP/OP sample being
collection (had no pathogens detected).
Enterovirus/rhinoviruses were the most commonly
detected viruses: 40% among non-fatal cases, 46% among
fatal cases and 39% among asymptomatic controls
(Additional file 1: Table S1). There was no difference in
enterovirus/rhinovirus detection between non-fatal and
asymptomatic controls (p = 0.87) and fatal and asymp-
tomatic controls (p = 0.40). The most commonly de-
tected bacteria was S. pneumoniae: 57% among non-fatal
cases, 61% among fatal cases and 58% among asymp-
tomatic controls. There was no difference in S.pneumo-
niae detection between non-fatal and asymptomatic
controls (p = 0.09) and fatal and asymptomatic controls
(p = 0.08) (Fig. 1). H. influenzae were less likely to be
detected among non-fatal cases (OR 0.08, 95% CI 0.02-
0.25) and fatal cases (OR 0.05, 95% CI 0.12-0.22)
compared to their respective asymptomatic controls
(Additional file 1: Table S2). However, for almost all
more frequently detected pathogens (i.e., adenovirus,
PIV-3, RSV, enterovirus/rhinovirus, Streptococcus pneu-
moniae, and Haemophilus influenzae), median Ct values
were lower for cases (fatal and non-fatal) than controls,
though these differences were not statistically significant
(Fig. 2). Enterovirus/rhinovirus had significantly lower
median Ct values among fatal cases compared to asymp-
tomatic controls (p < 0.01); and S. pneumoniae, had
significantly lower Ct values among non-fatal cases
compare to asymptomatic controls (p < 0.01).
Discussion
We detected multiple pathogens in NP/OP specimens col-
lected among non-fatal and fatal cases and asymptomatic
Fig. 1 Distribution of viruses and bacteria detected using Taqman array cards (TAC) among 72 non-fatal cases, 72 fatal cases, and 72 matched
asymptomatic control
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controls. Careful interpretation of results is needed since
over 80% of participants enrolled as asymptomatic con-
trols had at least one pathogen identified. Ct values may
play an important role when assessing etiological role of
pathogens detected in similar rates among cases and
controls.
Enterovirus/rhinovirus, RSV and adenovirus were the
leading viral pathogens detected from non-fatal and fatal
cases, similar to previous reports [4, 8, 9]. S. pneumoniae
was the leading bacterial pathogen detected in both non-
fatal and fatal cases (60%). These rates were within the
range observed from other studies, i.e., 55-75% [8, 10]. We
did not find substantial differences in pathogen detection
in cases (fatal and non-fatal) compared to controls. Other
studies have shown pathogens such as influenza virus,
RSV, rhinovirus, HMPV and Streptococcus pneumoniae
being detected more frequently in cases compared to
asymptomatic controls [9, 11, 12]. In fact, in our study, H.
influenzae had a 5 fold increase in detection rates among
asymptomatic controls compared to cases – even consid-
ering bacteria carriage as common in the population, this
may need further investigation. The 14 day symptom-free
period required for controls could have been too short,
some patients may be convalescent, coming for drug
refills. On the other hand, cases could have the distribu-
tion of bacterial pathogens in the respiratory tract altered
by previous antibiotic treatment [13].
Despite the lack of statistical significance, the median Ct
values for adenovirus, PIV-3, RSV, enterovirus/rhinovirus,
Streptococcus pneumonia, and Haemophilus influenzae
were lower among cases (fatal and non-fatal) compared to
asymptomatic controls; this could suggest an etiologic
contribution to the clinical presentation. Previous studies
have demonstrated that Ct values could be a proxy for
assessing concentration of pathogens and lower values
have been associated with disease severity [7]. Both fatal
and non-fatal cases positive for enterovirus/rhinovirus and
S. pneumoniae had significantly lower median Ct values
than asymptomatic controls. Assuming that Ct values
could be a proxy for pathogen density, enterovirus/rhino-
virus and S. pneumoniae could have played a role in the
pathogenesis of respiratory illness among case-patients.
High density of S. pneumoniae in the nasopharynx, for in-
stance, has been associated with pneumonia [14]. For fu-
ture studies using multi-pathogen diagnostic platform, the
strength of association between pathogen detected with
respiratory illness may have to be assessed relative to
pathogen loads in order to infer etiology.
Fig. 2 Box plot showing cycle threshold (Ct) values for agents targeted by Taqman Array Card (TAC) among 72 non-fatal cases, 72 fatal cases and
72 asymptomatic controls. Boxes show the median (dot and number) and the 25th and 75th percentiles and bars show the 10th and 90th
percentiles. *Pathogens whose median Ct value is significantly lower among non-fatal or fatal cases compared to asymptomatic controls using
Mann-Whitney test (Enterovirus/Rhinovirus median Ct: fatal-cases (23.23) vs asymptomatic controls (29.10), p value < 0.01; S.pneumoniae median
Ct: non-fatal cases (26.60) vs asymptomatic controls (29.34), p value <0.01)
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There were a number of limitations to this study. NP/
OP swabs are non-sterile-site specimens. Using a highly
sensitive molecular technique on non-sterile specimens
can detect small amounts of nucleic material even in
asymptomatic individuals who are either incubating or re-
covering from infection [15]. Our case definition was quite
broad. It is possible that some patients presented with
other illnesses such as malaria (endemic in this area) or
with nonspecific respiratory symptoms were misclassified
as having a respiratory disease. This may have reduced the
chances of detecting respiratory disease pathogens among
the cases. The low sample size in our study does not
afford the statistical power needed to determine an associ-
ation between most pathogens detected and respiratory
disease, despite the trend toward some pathogens of lower
Ct values (i.e., high concentration) amongst non-fatal and
fatal cases compared to controls.
Conclusions
Multi-pathogen molecular diagnostics such as TAC can
be useful for investigation of respiratory outbreaks of
unknown origin and to assess the distribution of patho-
gens in a defined population. However, the attribution of
pathogens as a cause of respiratory disease using this
technology needs to be further evaluated. This study
supports previous published studies suggesting the use
of Ct values to define clinically relevant pathogen con-
centrations. Further studies are warranted to investigate
and establish appropriate pathogen-specific Ct cutoff
values indicative of disease.
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